|
| CAP synoptic form item: Additional Pathologic Findings. |
| May contain organization-specific values: Yes |
| Category Entries: |
| None identified |
| Tumor necrosis |
| Degenerative changes |
| Dysplasia / adenoma |
| Crohn’s disease |
| Condyloma accuminatum |
| Dysplasia |
| Associated rectal carcinoma (Paget disease) |
| Appendicitis |
| Perforation, not at tumor |
| Chronic ulcerative colitis |
| Diverticulosis |
| Low-grade neuroendocrine tumor (carcinoid tumor) |
| Choledochal cyst |
| Primary sclerosing cholangitis |
| Stones |
| Cirrhosis / severe fibrosis (Ishak fibrosis score 5-6) |
| Biliary stones |
| Chronic hepatitis |
| Inflammatory bowel disease |
| Adenoma(s) |
| Chronic ulcerative proctocolitis |
| Dysplasia arising in inflammatory bowel disease |
| Other polyps |
| Hyperplasia |
| Atypical hyperplasia |
| Endometrial intraepithelial neoplasia (EIN) |
| Intestinal metaplasia (Barrett's esophagus) |
| Esophagitis |
| Gastritis |
| Salpingitis |
| Cholelithiasis |
| Chronic cholecystitis |
| Acute cholecystitis |
| Diffuse calcification (porcelain gallbladder) |
| Inflammation |
| Cirrhosis / fibrosis |
| Iron overload |
| Hepatitis |
| Hepatocellular dysplasia |
| Steatosis |
| Insufficient tissue, partial nephrectomy specimen <5mm adjacent non-neoplastic kidney |
| Glomerular disease |
| Tubulointerstitial disease |
| Vascular disease |
| Keratinizing dysplasia |
| Non-keratinizing dysplasia |
| Squamous metaplasia |
| Epithelial hyperplasia |
| Colonization |
| Atypical adenomatous hyperplasia |
| Squamous dysplasia |
| Metaplasia |
| Diffuse neuroendocrine hyperplasia |
| Emphysema |
| Sialadenitis |
| Tumor associated lymphoid proliferation |
| Asbestos bodies |
| Pleural plaque |
| Pulmonary interstitial fibrosis |
| Nevus remnant |
| Carcinoma in situ (Note M) |
| Epithelial dysplasia (Note M) |
| Endometriosis |
| Endosalpingiosis |
| Chronic pancreatitis |
| Acute pancreatitis |
| Adenomatosis (multiple endocrine tumors, each less than 5 mm in greatest dimension) |
| Pancreatic intraepithelial neoplasia |
| Ferruginous bodies |
| Mesothelial inclusion cysts |
| High-grade prostatic intraepithelial neoplasia (PIN) (Note F) |
| Nodular prostatic hyperplasia |
| Urothelial carcinoma in situ |
| Urothelial dysplasia (low-grade intraurothelial neoplasia) |
| Inflammation / regenerative changes |
| Therapy-related changes |
| Pyelitis cystica and / or glandularis |
| Keratinizing squamous metaplasia |
| Intestinal metaplasia |
| Lithiasis |
| Calcifications |
| Mitotic Rate: Number of mitoses per 40x objective with a field area of 0.152 mm2 |
| Apoptosis |
| Basophilic vascular deposits |
| Inflammatory cells |
| Hemorrhage |
| Neovascularization |
| Celiac disease |
| Polyp(s) |
| Intratubular germ cell neoplasia |
| Hemosiderin-laden macrophages |
| Atrophy |
| Age-appropriate involution changes |
| Fibrosis |
| Cortical hyperplasia |
| Cystic changes in tumor |
| Cystic changes in adjacent thymus |
| Adenomatoid nodule(s) or Nodular follicular disease (e.g., nodular hyperplasia, goitr |
| Diffuse hyperplasia (Graves’ disease) |
| Thyroiditis |
| Parathyroid gland(s) |
| C-cell hyperplasia |
| Implantation site |
| Cautery artifact |
| Ureteritis or pyelitis cystica and / or glandularis |
| Cystitis cystica glandularis |
| Koilocytosis |
| Intraepithelial neoplasia |
| Microvascular patterns |
| Vascular invasion (tumor vessels or other vessels) |
| Degree of pigmentation |
| Inflammatory cells / tumor infiltrating lymphocytes |
| Drusen |
| Retinal detachment |
| Invasion of Bruch’s membrane |
| Nevus |
| Adenoarcinoma in-situ |
| Carcinoma in-situ |
| Atypical Adenosis |
| Vulvar intraepithelial neoplasia (VIN) 3 (severe dysplasia / carcinoma in situ) |
| Other |
